| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3283 |
| Trial ID | NCT05659628 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | Tislelizumab |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL |
| Year | 2022 |
| Country | China |
| Company sponsor | Ningbo No. 1 Hospital |
| Other ID(s) | Ningbo101 |
| Cohort 1 | |||||||||||
|
|||||||||||